» Articles » PMID: 23960987

"Retinoblastoma Survival Disparity": The Expanding Horizon in Developing Countries

Overview
Specialty Ophthalmology
Date 2013 Aug 21
PMID 23960987
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

The patients' survival for the most common intraocular tumor in children, retinoblastoma, has a wide spectrum among the world countries. This study was conducted to provide an overview of the retinoblastoma survival disparity worldwide by discussing the trends of patients' survival, as well as recent advances in the management of retinoblastoma. The design of this study was literature review and commentary. Selected articles from PubMed (except one) including both developing and developed countries regarding the patients' survival in retinoblastoma were considered and reviewed critically. An analysis of 47 articles was performed. In conclusion, in spite of an obvious contrast of retinoblastoma survival disparity in the world, the expanding horizons in developing countries are promising and continuing on all fronts and results are hope-inspiring.

Citing Articles

Global, regional and national burden due to retinoblastoma in children aged younger than 10 years from 1990 to 2021.

Li C, Zhang L, Zhang J, Jiao J, Hua G, Wang Y BMC Med. 2024; 22(1):604.

PMID: 39736662 PMC: 11686879. DOI: 10.1186/s12916-024-03827-9.


Retinoblastoma in Ethiopian Children: Imaging Findings and Staging.

Woldeyohannes A, Wondimu B, Kefenie D, Legesse T, Issa S Ethiop J Health Sci. 2024; 34(Spec Iss 1):39-46.

PMID: 39735524 PMC: 11674751. DOI: 10.4314/ejhs.v34i1.7S.


Retinoblastoma programme outcome over a 10-year period in Lebanon: assessment of potential impact of the pandemic and economic crisis.

Al-Haddad C, Wehbi Z, Slim A, Hmede A, Jurdi Kheir W, Saab R Eye (Lond). 2024; 39(4):748-754.

PMID: 39562725 PMC: 11885430. DOI: 10.1038/s41433-024-03465-8.


Overall survival and cause-specific mortality in a hospital-based cohort of retinoblastoma patients in São Paulo, Brazil.

Ribeiro K, Veiga L, Carvalho Filho N, Morton L, Kleinerman R, Antoneli C Int J Cancer. 2024; 156(1):69-78.

PMID: 39138799 PMC: 11537822. DOI: 10.1002/ijc.35127.


Advancements in Retinoblastoma Treatment: Unraveling the Potential of Intravitreal Chemotherapy.

Tanveer S, Zafar F, Bibi H, Haroon H, Ahmad O, Iqbal M Cureus. 2024; 16(1):e53012.

PMID: 38410326 PMC: 10895558. DOI: 10.7759/cureus.53012.


References
1.
Erwenne C, Franco E . Age and lateness of referral as determinants of extra-ocular retinoblastoma. Ophthalmic Paediatr Genet. 1989; 10(3):179-84. DOI: 10.3109/13816818909009874. View

2.
Nasution R, Sutjipto A . Childhood retinoblastoma. Paediatr Indones. 1991; 31(3-4):117-22. View

3.
Leal-Leal C, Flores-Rojo M, Medina-Sanson A, Cerecedo-Diaz F, Sanchez-Felix S, Gonzalez-Ramella O . A multicentre report from the Mexican Retinoblastoma Group. Br J Ophthalmol. 2004; 88(8):1074-7. PMC: 1772266. DOI: 10.1136/bjo.2003.035642. View

4.
Canturk S, Qaddoumi I, Khetan V, Ma Z, Furmanchuk A, Antoneli C . Survival of retinoblastoma in less-developed countries impact of socioeconomic and health-related indicators. Br J Ophthalmol. 2010; 94(11):1432-6. DOI: 10.1136/bjo.2009.168062. View

5.
Kingston J, Hungerford J, Madreperla S, Plowman P . Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma. Arch Ophthalmol. 1996; 114(11):1339-43. DOI: 10.1001/archopht.1996.01100140539004. View